LD-2 disclosure · 4th Quarter - Report
AVANIR PHARMACEUTICALS
Expenses$98Kself-filed spend
Client
- Location
- California · United States of America
Registrant
- Description
- ​Central Nervous System Pharmaceutical Research and Development/Pharmaceutical Sales
- Location
- Aliso Viejo, California, United States of America
Lobbying activities
1 issueHealth Issues
SGR Repeal, 21st Century Cures, Specialty Tier Price Cap Legislation, Patent Reform, Health Care Quality Measures
LobbyistsCRYSTAL LYNN VANUCH · SARAH CHRISTINE D'ORSIE
Covered position (CRYSTAL LYNN VANUCH): Head of Government Affairs
Covered position (SARAH CHRISTINE D'ORSIE): Director of Advocacy
TargetedSENATE · HOUSE OF REPRESENTATIVES · Agency for Healthcare Research & Quality (AHRQ) · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS)